In vivo TLR9 inhibition attenuates CpG-induced myocardial dysfunction.
Boehm O, Markowski P, van der Giet M, Gielen V, Kokalova A, Brill C, Hoeft A, Baumgarten G, Meyer R, Knuefermann P.
Boehm O, et al. Among authors: knuefermann p.
Mediators Inflamm. 2013;2013:217297. doi: 10.1155/2013/217297. Epub 2013 Apr 10.
Mediators Inflamm. 2013.
PMID: 23690658
Free PMC article.